Mirum Pharmaceuticals saw the highest growth of 6.99% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.32% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Mirum Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Mirum Pharmaceuticals has been focused on protecting inventions in United States(US) with four publications in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 36% of filings. The United States(US), Israel(IL), Colombia(CO), and Australia(AU) patent Office are among the top ten patent offices where Mirum Pharmaceuticals is filings its patents. Among the top granted patent authorities, Mirum Pharmaceuticals has 100% of its grants in European Patent Office(EPO).
Bayer and Gilead Sciences could be the strongest competitors for Mirum Pharmaceuticals
In terms of grant share, Mirum Pharmaceuticals stands in third position among its competitors. Bayer and Gilead Sciences secured the top positions according to recent patent publication data.
Patents related to remote patient monitoring and rare diseases lead Mirum Pharmaceuticals's portfolio
Mirum Pharmaceuticals has the highest number of patents in remote patient monitoring followed by, rare diseases and genomics. For remote patient monitoring, nearly 60% of patents were filed and no patents were granted in Q2 2024.
Liver diseases related patents lead Mirum Pharmaceuticals portfolio followed by cholestasis, and pruritus
Mirum Pharmaceuticals has highest number of patents in liver diseases followed by cholestasis, pruritus, progressive familial intrahepatic cholestasis, and alagille syndrome. For liver diseases, nearly 29% of patents were filed and 50% of patents were granted in Q2 2024.
For comprehensive analysis of Mirum Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
